SCHEMBL10935341

SCHEMBL10935341

CCOC(=O)CSC[C@H](NC(C)C(=O)N1CCC[C@H]1C(=O)OC(C)(C)C)C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ ACE P12821 9/20 0.49
▸ LMNA P02545 1/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ ABCB11 O95342 1/20 0.36
▸ FKBP1A P62942 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ PDE3A Q14432 1/20 0.33
▸ PEPD P12955 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10935346 1.00 CYP1A2 (0.50) CYP1A2CYP2C9CYP2C19HTTACE
SCHEMBL10520357 0.89 ACE (0.45) CYP1A2CYP2C9CYP2C19HTTACE
SCHEMBL10520350 0.89 ACE (0.45) CYP1A2CYP2C9CYP2C19HTTACE
SCHEMBL10799424 0.88 ACE (0.62) ACELMNASMN1; SMN2ABCB11MAPT
SCHEMBL10799388 0.88 ACE (0.62) ACELMNASMN1; SMN2ABCB11MAPT
SCHEMBL10520981 0.87 ACE (0.50) ACELMNASMN1; SMN2ABCB11FKBP1A
SCHEMBL10520986 0.87 ACE (0.50) ACELMNASMN1; SMN2ABCB11FKBP1A
SCHEMBL10520254 0.84 ACE (0.45) CYP1A2CYP2C9CYP2C19HTTACE
SCHEMBL10520260 0.84 ACE (0.45) CYP1A2CYP2C9CYP2C19HTTACE
SCHEMBL10521977 0.84 ACE (0.44) CYP1A2CYP2C9CYP2C19HTTACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-60185762-A — — None — — JP disclosed
JP-S60185762-A PROLINE DERIVATIVE OTSUKA PHARMACEUT FACTORY INC 1985-09-21 — — JP disclosed
Send feedback